Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7603-7613

  Bagnarelli, Patrizia ^a   Valenza, Anna ^a   Menzo, Stefano ^a   Sampaolesi, Riccardo ^a   Varaldo, Pietro E ^a   Butini, Luca ^a   Montroni, Maria ^a   Perno, Carlo Federico ^b   Aquaro, Stefano ^b   Mathez, Dominique ^e   Leibowitch, Jacques ^e   Balotta, Claudia ^c   Clementi, Massimo ^d  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e Centre d'Immuno Virologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL MATURATION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS TRANSCRIPTION; VISNA VIRUS;

EID: 10244225287     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7603-7613.1996     Document Type: Article

References (84)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal. 1985. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69-73.
3. Bagnarelli, P., D. Mathez, D. Paul, C. Katlama, P. de Truchis, A. Valenza, M. Clementi, and J. Leihowitch. 1996. Dynamics and compartmentalization of HIV-1 biotypes in vivo. AIDS Sci. 1:81-90.
4. Bagnarelli, P., S. Menzo, A. Manzin, M. Giacca, P. E. Varaldo, and M. Clementi. 1991. Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse transcription polymerase chain reaction. J. Med. Virol. 34:89-95.
5. Bagnarelli, P., S. Menzo, A. Valenza, A. Manzin, M. Giacca, F. Ancarani, G. Scalise, P. E. Varaldo, and M. Clementi. 1992. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J. Virol. 66:7328-7335.
6. Bagnarelli, P., S. Menzo, A. Valenza, S. Paolucci, S. Petroni, G. Scalise, R. Sampaolesi, A. Manzin, P. E. Varaldo, and M. Clementi. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J. Clin. Microbiol. 33: 16-23.
7. Bagnarelli, P., A. Valenza, S. Menzo, A. Manzin, G. Scalise, P. E. Varaldo, and M. Clementi. 1994. Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J. Virol. 68:2495-2502.
8. Baumberger, C., S. Kinloch-de-Loes, S. Yerly, B. Hirschel, and L. Perrin. 1993. High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS 7(Suppl. 2):S59-S64.
9. Bruggeman, L. A., M. M. Thomson, P. J. Nelson, J. B. Kopp, J. Rappaport, P. E. Klotman, and M. E. Klotman. 1994. Patterns of HIV-1 mRNA expression in transgenic mice arc tissue-dependent. Virology 202:940-948.
10. Butera, S. T., B. D. Roberts, L. Lam, T. Hodge, and T. M. Folks. 1994. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J. Virol. 68: 2726-2730.
11. Centers for Disease Control and Prevention. 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41:1-19.
12. Chang, D. D., and P. A. Sharp. 1990. Messenger RNA transport and HIV rev regulation. Science 249:614-615.
13. Chen, Z. W., Z. C. Kou, L. Shen, J. D. Regan, C. I. Lord, M. Halloran, D. Lee-Parrilz, P. N. Fultz, and N. L. Letvin. 1994. An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes. Proc. Natl. Acad. Sci. USA 91:7501-7505.
14. Clementi, M., P. Bagnarelli, S. Menzo, A. Valenza, A. Manzin, and P. E. Varaldo. 1993. Clearance of HIV-1 viremia after seroconversion. Lancet 341:315-316.
15. Clementi, M., A. Manzin, P. Bagnarelli, S. Menzo, P. E. Varaldo, and G. Carloni. 1992. Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. Arch. Virol. 126:1-9.
16. Clementi, M., S. Menzo, P. Bagnarelli, A. Valenza, S. Paolucci, R. Sampaolesi, A. Manzin, and P. E. Varaldo. 1996, Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 9:135-147.
17. Clements, J. E., R. J. Wall, O. Narayan, D. Hauer, R. Schoborg, D. Sheffer, A. Powell, L. M. Carruth, M. C. Zink, and C. E. Rexroad. 1994. Development of transgenic sheep that express the visna virus envelope gene. Virology 200:370-380.
18. Clements, J. E., and F. Wong-Staal. 1992. Molecular biology of lentiviruses. Semin. Virol. 3:137-146.
19. Clements, J. E., and M. C. Zink. 1996. Molecular biology and pathogenesis of animal lentivirus infections. Clin. Microbiol. Rev. 9:100-117.
20. Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T-cell clone. J. Immunol. 142:431-438.
21. Coffin, J. M. 1995. HIV population dynamics in vivo: implication for genetic variations, pathogenesis, and therapy. Science 267:483-489.
22. Cullen, B. R., and W. C. Greene. 1989. Regulatory pathways governing HIV-1 replication. Cell 58:423-426.
23. Englund, G., T. S. Theodore, E. O. Freed, A. Engelman, and M. A. Martin. 1995. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J. Virol. 69:3216-3219.
24. Ensoli, B., P. Lusso, F. Schacter, S. F. Josephs, J. Rappaport, F. Negro, R. C. Gallo, and F. Wong-Staal. 1989. Human herpesvirus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 8:3019-3027.
25. Ensoli, F., A. Cafaro, V. Fiorelli, B. Vannelli, B. Ensoli, and C. J. Thiele. 1995. HIV-1 infection in primary human neuroblasts. Virology 210:221-225.
26. Fauci, A. S. 1993. New concepts in the immunopathogenesis of HIV infection. N. Engl. J. Med. 328:327-335.
27. Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
28. Feinberg, M. B., R. F. Jarret, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
29. Felber, B. K., C. M. Hadzopoulou, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
30. Fisher, U., S. Meyer, M. Teufel, C. Heckel, R. Luhrmann, and G. Rautmann. 1994. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:4105-4112.
31. Folks, T. M., S. Benn, A. Rabson, T. Theodore, M. D. Hoggan, M. Martin, M. Lightfoote, and K. Sell. 1985. Characterization of a continuous T-cell line susceptible to the cytopathic effect of the acquired immunodeficiency syndrome (AIDS) associated retrovirus. Proc. Natl. Acad. Sci. USA 82:4539-4543.
32. Folks, T. M., K. A. Clouse, J. Justement, A. Rabson, E. Duh, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2368.
33. Folks, T. M., J. Justement, A. Kinter, S. Schnittmann, J. Orenstein, G. Poli, and A. S. Fauci. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140:1117-1122.
34. Fultz, P. N. 1994. SIVsmmPBj14: an atypical lentivirus. Curr. Top. Microbiol. Immunol. 188:65-76.
35. Fultz, P. N., and P. M. Zack. 1994. Unique lentivirus-host interactions: SIVsmmPBj14 infection of macaques. Virus Res. 32:205-225.
36. Furtado, M. R., L. A. Kingsley, and S. M. Wolinsky. 1995. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. J. Virol. 69:2092-2100.
37. Furtado, M. R., R. Murphy, and S. M. Wolinsky. 1993. Quantitation of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of anti-retroviral therapy. J. Infect. Dis. 167:213-216.
38. Gallo, R. C. 1995. Human retroviruses in the second decade: a personal perspective. Nat. Med. 1:753-759.
39. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
40. Gilles, P. N., J. L. Lathey, and S. A. Spector. 1995. Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact. J. Virol. 69:2133-2139.
41. Gonda, M. A. 1994. Molecular biology and virus-host interactions of lentiviruses. Ann. N.Y. Acad. Sci. 724:22-42.
42. Greene, W. C. 1990. Regulation of HIV-1 gene expression. Annu. Rev. Immunol. 8:453-475.
43. Guatelli, J. C., T. R. Gingeras, and D. D. Richman. 1990. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J. Virol. 64:4093-4098.
44. Haase, A. T. 1986. Pathogenesis of lentivirus infections. Nature (London) 322:130-136.
45. Haase, A. T. 1994. The role of active and covert infections in lentivirus pathogenesis. Ann. N.Y. Acad. Sci. 724:75-86.
46. Haynes, B. F., G. Pantaleo, and A. S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324-328.
47. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
48. Holodniy, M., L. Mole, D. Margolis, J. Moss, H. Dong, E. Boyer, M. Urdea, J. Kolberg, and S. Eastman. 1995. Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy. J. Virol. 69:3510-3516.
49. Jurriaans, S., G. J. Weverling, J. Goudsmit, J. Boogaard, M. Brok, D. van Strijp, J- Lange, M. Koot, and B. van Gamen. 1995. Distinct changes in HIV type 1 RNA versus p24-antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS. AIDS Res. Hum. Retroviruses 11:473-479.
50. Kim, S. Y., R. Bryn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection for differential gene expression. J. Virol. 63:3708-3713.
51. Klotman, M. E., S. Kim, A. Buchbinder, R. A. De, D. Baltimore, and F. Wong-Staal. 1991. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88:5011-5015.
52. Laspia, M. F., A. P. Rice, and M. B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
53. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, J. H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
54. Malim, M. H., J. Hauber, S. Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338:254-257.
55. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
56. Menzo, S., P. Bagnarelli, M. Giacca, A. Manzin, P. E. Varaldo, and M. Clementi. 1992. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J. Clin. Microbiol. 30:1752-1757.
57. Michael, N. L., T. Mo, A. Merzouki, M. O'Shaughnessy, C. Oster, D. S. Burke, R. R. Redfield, D. L. Birx, and S. A. Cassol. 1995. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J. Virol. 69:1868-1877.
58. Michael, N. L., P. Morrow, J. Mosca, M. Vahey, D. S. Burke, and R. R. Redfield. 1991. Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J. Virol. 65:1291-1303.
59. Michael, N. L., M. Vahey, D. S. Burke, and R. R. Redfield. 1992. Viral DNA and RNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J. Virol. 66:310-316.
60. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
61. Neumann, M., J. Harrison, M. Saltarelli, E. Hadziyannis, V. Ertle, B. K. Felber, and G. N. Pavlakis. 1994. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 10:1531-1542.
62. O'Reilly, M. M., M. T. McNally, and K. L. Beemon. 1995. Two strong 5′ splice sites and competing suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 213:373-385.
63. Pantaleo, G., and A. S. Fauci. 1994. Tracking HIV during disease progression. Curr. Opin. Immunol. 6:600-604.
64. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The role of lymphoid organs in the pathogenesis of HIV infection. Semin. Immunol. 5:157-163.
65. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, J. B. Margolick, S. Buchbinder, J. V. Giorgi, and A. S. Fauci. 1995. Studies on subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 322:209-216.
66. Peng, H., T. A. Reinhart, E. F. Retzel, K. A. Staskus, M. Zupantic, and A. T. Haase. 1995. Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology 206:16-27.
67. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance, infected cell life-span, and viral generation time. Science 271:1582-1586.
68. Perno, C. F., and R. Yarchoan. 1993. Culture of HIV in monocytes and macrophages. Curr. Prot. Immunol. 12:1-11.
69. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
70. Pomerantz, R. J., D. Trono, M. B. Feimberg, and D. Baltimore. 1990. Cells productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271-1276.
71. Purcell, D. F. J., and M. A. Martin. 1993. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67:6365-6368.
72. Saksela, K., C. Stevens, P. Rubinstein, and D. Baltimore. 1994. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the number of CD4+ lymphocytes. Proc. Natl. Acad. Sci. USA 91:1104-1108.
73. Scadden, D. T., Z. Wang, and J. E. Groopma. 1992. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J. Infect. Dis. 165:1119-1123.
74. Schnittman, S. M., J. J. Greenhouse, H. C. Lane, P. F. Pierce, and A. S. Fauci. 1991. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. AIDS Res. Hum. Retroviruses 7:361-367.
75. Schwartz, S., B. K. Felber, D. M. Benko, E. M. Fenyö, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
76. Schweibert, R., and P. N. Fultz. 1994. Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in viva events. J. Virol. 68:5538-5547.
77. Seshamma, T., O. Bagasra, D. Trono, D. Baltimore, and R. J. Pomerantz. 1992. Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:10663-10667.
78. Sheppard, H. W., W. Lang, M. S. Ascher, E. Vittinghoff, and W. Winkestein. 1993. The characterization of non-progressors: long-term HIV-1 infection with a stable CD4+ T-cell levels. AIDS 7:1159-1166.
79. Toohey, K. L., and A. T. Haase. 1994. The rev gene of visna virus is required for productive infection. Virology 200:276-280.
80. Tornatore, C., K. Meyers, W. Atwood, K. Conant, and E. Major. 1994. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 68:93-102.
81. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoefer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
82. Weiss, R. A. 1993. How does HIV cause AIDS? Science 260:1273-1279.
83. Williams, L. M., and M. V. Cloyd. 1991. Polymorphic human gene(s) determine differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184:723-728.
84. Zazopoulos, E., and W. A. Haseltine. 1993. Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology 194:20-27.